Results
|
|
1521.
|
|
|
|
1522.
|
|
|
|
1523.
|
|
|
|
1524.
|
|
|
|
1525.
|
|
|
|
1526.
|
|
|
|
1527.
|
|
|
|
1528.
|
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. [electronic resource] by
- Lee, Jung-Min
- Nair, Jayakumar
- Zimmer, Alexandra
- Lipkowitz, Stanley
- Annunziata, Christina M
- Merino, Maria J
- Swisher, Elizabeth M
- Harrell, Maria I
- Trepel, Jane B
- Lee, Min-Jung
- Bagheri, Mohammad H
- Botesteanu, Dana-Adriana
- Steinberg, Seth M
- Minasian, Lori
- Ekwede, Irene
- Kohn, Elise C
Producer: 20190125
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
|
1529.
|
|
|
|
1530.
|
|
|
|
1531.
|
Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked. [electronic resource] by
- Scrace, Simon F
- Kierstan, Peter
- Borgognoni, Jenifer
- Wang, Lan-Zhen
- Denny, Sarah
- Wayne, Joanne
- Bentley, Carol
- Cansfield, Andrew D
- Jackson, Philip S
- Lockie, Andrea M
- Curtin, Nicola J
- Newell, David R
- Williamson, Douglas S
- Moore, Jonathan D
Producer: 20090316
In:
Cell cycle (Georgetown, Tex.) vol. 7
Availability: No items available.
|
|
|
1532.
|
|
|
|
1533.
|
|
|
|
1534.
|
|
|
|
1535.
|
|
|
|
1536.
|
|
|
|
1537.
|
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. [electronic resource] by
- Fokas, E
- Prevo, R
- Pollard, J R
- Reaper, P M
- Charlton, P A
- Cornelissen, B
- Vallis, K A
- Hammond, E M
- Olcina, M M
- Gillies McKenna, W
- Muschel, R J
- Brunner, T B
Producer: 20130531
In:
Cell death & disease vol. 3
Availability: No items available.
|
|
|
1538.
|
|
|
|
1539.
|
|
|
|
1540.
|
|